Prescription drug re-importation: A balanced look

Journal of Gerontological Nursing

Volumn 32, Issue 8, 2006, Pages 15-19

  Ornes, Lynne ^a   Hendrix, Thomas J ^b  

^a SOUTHERN UTAH UNIVERSITY   (United States)

^b UNIVERSITY OF ALASKA ANCHORAGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COMMERCIAL PHENOMENA; DRUG COST; DRUG INDUSTRY; DRUG LEGISLATION; ECONOMICS; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HUMAN; INTERNATIONAL COOPERATION; INTERNET; ORGANIZATION AND MANAGEMENT; PRESCRIPTION; REVIEW; SAFETY; UNITED STATES; UTILIZATION REVIEW;

AGED; COMMERCE; DRUG COSTS; DRUG INDUSTRY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; INTERNET; LEGISLATION, DRUG; PRESCRIPTIONS, DRUG; SAFETY MANAGEMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33749050572     PISSN: 00989134     EISSN: None     Source Type: Journal    
DOI: 10.3928/00989134-20060801-04     Document Type: Article

References (36)

1. American Association of Retired Persons. (2004). Prescription drug re-importation question and answer sheet. Retrieved from http://assets.aarp.org/www.aarp.org_/articles/international/ ReimportationQA.pdf.
2. Annenberg Public Policy Center of the University of Pennsylvania. (2002). Issue ads. Retrieved from www.annenbergpublicpolicycenter.org/issueads/organizations/PhRMA.htm.
3. Annenberg Public Policy Center of the University of Pennsylvania. (2003). Issue ads APPC - Pharmaceutical Research and Manufacturers of America. Retrieved from www.appcpenn.org/issueads/organizations/ PhRMA.html.
4. Appleby, J. (2004). Regulators get tougher on counterfeit drugs. USA Today, Section B, p. 1.
5. Associated Press. (2004, August 12). Candidates debate drug import policy. Salt Lake Tribune, p. A10.
6. Bast, D.C. (2003). What is drug "reimportation"? Retrieved from www.heartland.org/Printer Friendly.cfm?theType=artId&theID=12766.
7. Center for Responsive Politics. (n.d.). PhRMA total lobbying expenditures and lobbying firms hired by PhRMA. Retrieved from www.opensecrets.org/lobbyists/clients.asp?ID=99122&year=2000.
8. Clark, M. (2001). Prescription relief for the elderly. Nursing News, 25(1), 4.
9. Congressional Digest. (2003). Evolution of current law: Timeline of drug regulation in the United States. Congressional Digest, 260-265.
10. Conry, M. (2004). Polypharmacy: Pandora's medicine chest? Geriatric Times, 1(3). Retrieved from www.geriatrictimes.com/g001028.html.
11. Dorschner, J. (2004, August 4). Canada feels squeeze from drug makers. The Miami Herald. Retrieved from www.miami.com/mld/miamiherald/ business/9314233.htm?1c.
12. Espicom Healthcare Intelligence. (2005). Drug internet sales in the USA: Causes and challenges. Retrieved from www.marketresearch.com/ product/display.asp?productid-1095688&xs=r.
13. Federal Register. (2000). Prescription Drug Marketing Act of 1987 with Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Federal Register, 65(86), 25639-25641. Retrieved from http://web.lexis-nexis.com/congcomp/printdoc.
14. Food and Drug Administration. (2003). FDA/US Customs import blitz exams reveal hundreds of potentially dangerous imported drug shipments. Retrieved from www.fda.gov/topics/NEWS/2003/NEW00948.html.
15. Food and Drug Administration. (2004). Counterfeit drugs questions and answers. Retrieved from www.fda.gov/oc/initiatives/counterfeit/ qa.html.
16. Goldberg, R. (2000). Reimporting prescription drugs. National Center for Policy Analysis: Brief analysis No. 342. Retrieved from www.ncpa.org/ba/ba342/ba342.html.
17. GovTrackus. (n.d.). Tracking the US Congress. Retrieved from www.govetrackus/congress/bill.xpd?=S108.2328.
18. Gross, D. (2001). Trends in the costs, coverage, and use of prescription drugs by Medicare beneficiaries. Retrieved from http://research.aarp.org/health/dd63_trends.html.
19. Health Care Distribution Management Association. (2002). HDMA addresses the issue of counterfeit drugs. Retrieved from http://66.23.131.26/press_room/pdf/2002_dec23_counterfeiting.pdf.
20. Health Care Distribution Management Association. (2004). HDMA mission. Retrieved from www.healthcaredistribution.org/ ?p=29929&cm_c=82006.
21. Henderson, D.R., & Hooper, C. (2004, March 4). The re-importation blackmail. Washington Times. Retrieved from http://nl.newsbank.com/nl-search/we/Archives?p_product=WT&p_theme= wt&pt́ion=search&px̄docs=200&p_text_ search-0=Henderson%20AND%20Hooper&s_dispstring= Henderson%20Hooper%20AND%20date(2004)&p_field_date- 0=YMD&_date&p_params_date-0=date:B,E&p_text_date-0= 2004&p_perpage=10&p_sort=YMD⊣te:D&xcal_useweights= no::.
22. International Herald Tribune. (2005). Small U.S. pharmacies fear insurers' new plan. Retrieved from www.iht.com/articles/2005/01/03/ business/pharma.php.
23. Kaiser Family Foundation. (2003, May). Prescription drug trends. Retrieved from www.kff.org/rxdrugs/loader.cfm?url=/commonspot/security/ getfile.cfm&PageID=14267.
24. Kaiser Family Foundation. (2006, June). Tracking prescription drug coverage under Medicare: Five ways to look at new enrollment numbers. Retrieved June 30, 2006 from www.kff.org/medicare/upload/7466.pdf
25. Kouzoukas, D. (2002). Rx reimportation: A legislative history. Retrieved from www.heartland.org/Article.cfm?artId=10669.
26. Kratz, V. (2002). Prescription drug benefits: Lobbies force a bitter pill. Newsday, p. B4. Retrieved from www.biohope.org/media/ article∥int.cfm?articleid+2906.
27. National Community Pharmacists Association. (2004). NCPA position statements. Retrieved from www.ncpanet.org/about/ ncpa∝sition§atements/d.shtml#10.
28. Open Secrets. (2000). Prescription drugs: What's the issue? Retrieved from www.opensecrets.org/news/drug/.
29. Pharmaceutical Research and Manufacturers of America. (2002, July 17). Press release. Retrieved from www.phrma.org/mediaroom/press/ releases///17.07.2002.462.cfm.
30. Pharmaceutical Research and Manufacturers of America. (2004). Who we are. Retrieved from www.phrma.org/whoweare/.
31. Pipes, S. (2003, October 14). Drug importation: The year's hottest policy debate. Retrieved from www.pacificresearch.org/pub/sab/entrep/ speech_sally_reimportation.html.
32. Rouhi, M. (2002). Beyond Hatch-Waxman. Chemical & Engineering News. Retrieved from http://pubs.acs.org/cen/coverstory/8038/ 8038biogenerics2.html.
33. Schumock, G., & Walton, S. (2003, October). Expenditures for prescription drugs: Too much or not enough? Healthcare Financial Management. Retrieved from www.findarticles.com/cf_dls/m3257/10_57/ 109181210/print.jhtml.
34. Turner, G., & Meier, C. (2004). Prescription drug importation: Just the facts. Retrieved from www.heartland.org/ Article.cfm?artId=15038.
35. U.S. Senate. (2004). Reliable Entry for Medicines at Everyday Discounts Through Importation with Effective Safeguards Act of 2004; S.2307. Retrieved from http://thomas.loc.gov/cgi-bin/query/ D?c108:10:./temp/-c108vojkWS::.
36. Vogt, D.U., & Randell, B. (2001). Prescription drugs: Importation for personal use. Congressional Research Service. Retrieved from www.law.umaryland.edu/marshall/Electronic Resources/crsreports/ crsdocuments/RS20996.pdf.